The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PSA response and survival based on metastatic site in patients with metastatic castration resistant prostate cancer (mCRPC) treated with lutetium-177-PSMA-vipivotide tetraxetan (Lu177-PVT).
 
Joseph Allen
No Relationships to Disclose
 
Colin Bergstrom
No Relationships to Disclose
 
Hong Song
Consulting or Advisory Role - Lanth; Lanth
Research Funding - Clarity Pharmaceuticals (Inst)
 
Catiussi Hoffmann
No Relationships to Disclose
 
Shann Ruiz
No Relationships to Disclose
 
Joanne Chien
No Relationships to Disclose
 
Kaidi Moore
No Relationships to Disclose
 
Divya Parikh
No Relationships to Disclose
 
Sumit Shah
No Relationships to Disclose
 
Alice Fan
No Relationships to Disclose
 
Sandy Srinivas
Consulting or Advisory Role - Eisai; Janssen Oncology; Novartis; Seagen
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Merck (Inst); Seattle Genetics/Astellas (Inst)
Other Relationship - Pfizer
 
Andrei Iagaru
Consulting or Advisory Role - Alpha9Tx; Clarity Pharmaceuticals; Isotopen Technologien; Lilly; Novartis; Radionetics; Telix Pharmaceuticals
Research Funding - Advanced Accelerator Applications (Inst); GE Healthcare (Inst); Progenics (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Ali Khaki
Honoraria - HMP
Consulting or Advisory Role - Gilead Sciences (Inst)
Research Funding - 23andMe (Inst); Acrivon Therapeutics (Inst); Janssen Oncology (Inst); Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Janssen; Pfizer/Astellas